- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04560868
Development of a mHealth Intervention for Ambivalent Smokers
January 3, 2023 updated by: Kaiser Permanente
The current pilot study will assess the feasibility and acceptability of a novel mHealth app designed for people who are ambivalent about quitting smoking.
Results will be used to refine the intervention and plan for a future randomized effectiveness trial.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98101
- Kaiser Permanente Washington Health Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years or older;
- Can speak/read English;
- Current smoker;
- Own and regularly use an eligible smartphone;
- No vision impairments;
- Willing to install and use the study program;
- Willing to use birth control if elect to use nicotine replacement during the study (females);
- Meet definition for ambivalence
- Not actively using treatment
Exclusion Criteria:
- Smoke less than 10 cigarettes per day
- Self-report a lifetime history of dementia, manic depression, bipolar disorder, or schizophrenia;
- Have medical contraindications for nicotine replacement therapy;
- Another household member is enrolled in the study
- Unable to verify contact information
- Fail to install app
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
|
Participants in both arms can earn the ability to request a 2-week supply of over-the-counter nicotine patches.
Patches are earned through accumulated use of the assigned mHealth program.
The intervention includes a mHealth intervention that is grounded in best practice recommendations for treatment of nicotine dependence.
Experimental participants also receive additional content designed to motivate smoking reduction/quitting and provide skills training.
|
|
Active Comparator: Control
|
The intervention includes a mHealth intervention that is grounded in best practice recommendations for treatment of nicotine dependence.
Participants in both arms can earn the ability to request a 2-week supply of over-the-counter nicotine patches.
Patches are earned through accumulated use of the assigned mHealth program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program Engagement
Time Frame: Assessed at 3-month follow-up
|
Number of unique app user-sessions
|
Assessed at 3-month follow-up
|
|
Quit Attempt Lasting at Least 24 Hours
Time Frame: Assessed at 3-month follow-up
|
At least one intentional smoking quit attempt lasting at least 24 hours.
Missing outcomes imputed as not making a quit attempt.
|
Assessed at 3-month follow-up
|
|
Not Smoking (Even a Puff) in the Last 7 Days
Time Frame: Assessed at 3-month follow-up
|
7-day point prevalent abstinence: self-report of not smoking, even a puff, in the last 7 days.
Missing values were imputed as smoking.
|
Assessed at 3-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction With Assigned App
Time Frame: Assessed at 1 month
|
Satisfaction with the overall "content and advice" of the assigned app, rated on a Likert scale from 1="not at all satisfied" to 5="extremely satisfied".
|
Assessed at 1 month
|
|
Satisfaction With Assigned App
Time Frame: Assessed at 3 months
|
Satisfaction with the overall "content and advice" of the assigned app on a Likert scale from 1="not at all satisfied" to 5="extremely satisfied".
|
Assessed at 3 months
|
|
Helpfulness of Assigned App
Time Frame: Assessed at 1 month.
|
Global helpfulness rating calculated as the average helpfulness rating of 8 app features, each rated on a Likert scale from 1="not at all helpful" to 5="extremely helpful".
|
Assessed at 1 month.
|
|
Helpfulness of Assigned App
Time Frame: Assessed at 3 months
|
Average helpfulness rating of 8 separate app features, with each feature rated on a Likert scale from 1="not at all helpful" to 5="extremely helpful".
|
Assessed at 3 months
|
|
Program Engagement - Earned Badges
Time Frame: Assessed at 1-month follow-up
|
Number of accumulated badge rewards earned from using the assigned app.
|
Assessed at 1-month follow-up
|
|
Program Engagement - Earned Badges
Time Frame: Assessed at 3-month follow-up
|
Number of accumulated badge rewards earned from using the assigned app.
|
Assessed at 3-month follow-up
|
|
Self-efficacy to Quit Smoking
Time Frame: Assessed at 1 month
|
Self-reported confidence in quitting smoking on Likert scale from 1="not at all" to 10="extremely".
|
Assessed at 1 month
|
|
Self-efficacy to Quit Smoking
Time Frame: Assessed at 3 months
|
Self-reported confidence in quitting smoking on a Likert scale from 1="not at all" to 10="extremely".
|
Assessed at 3 months
|
|
Self-efficacy to Stay Quit
Time Frame: Assessed at 1 month
|
Self-reported confidence in ability to stay quit on a Likert scale from 1="not at all" to 10="extremely".
|
Assessed at 1 month
|
|
Self-efficacy to Stay Quit
Time Frame: Assessed at 3 months
|
Self-reported confidence in ability to stay quit (if no smoking in the past 7 days) on a Likert scale from 1="not at all" to 10="extremely".
|
Assessed at 3 months
|
|
Earned and Requested Free Nicotine Replacement Therapy
Time Frame: Assessed at 1-month follow-up
|
Earned and requested free nicotine replacement therapy (NRT); free NRT could be earned by earning 6 app utilization badges.
|
Assessed at 1-month follow-up
|
|
Earned and Requested Free Nicotine Replacement Therapy
Time Frame: Assessed at 3-month follow-up
|
Earned and requested free nicotine replacement therapy (NRT); free NRT could be earned by earning 6 app utilization badges.
|
Assessed at 3-month follow-up
|
|
Quit Attempt Lasting at Least 24 Hours
Time Frame: Assessed at 1 month follow-up
|
At least one intentional smoking quit attempt lasting at least 24 hours; non-respondents were assumed to not have a successful quit attempt.
|
Assessed at 1 month follow-up
|
|
Change in Cigarettes/Day
Time Frame: Assessed at baseline and 1 month
|
Change in number of cigarettes smoked per day from baseline, calculated as (1 month)-baseline.
|
Assessed at baseline and 1 month
|
|
Change in Cigarettes/Day
Time Frame: Assessed at baseline and 3 months
|
Change in number of cigarettes smoked per day from baseline, calculated as (3 months)-baseline.
|
Assessed at baseline and 3 months
|
|
Refrain From Smoking (Even a Puff) in the Last 7 Days
Time Frame: Assessed at 1-month follow-up
|
7-day point prevalent abstinence: a self-report of not smoking, even a puff, in the past 7 days.
Missing outcomes were imputed as smoking.
|
Assessed at 1-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jennifer McClure, PhD, Kaiser Permanente
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 16, 2020
Primary Completion (Actual)
September 27, 2021
Study Completion (Actual)
September 27, 2021
Study Registration Dates
First Submitted
June 15, 2020
First Submitted That Met QC Criteria
September 17, 2020
First Posted (Actual)
September 23, 2020
Study Record Updates
Last Update Posted (Actual)
January 23, 2023
Last Update Submitted That Met QC Criteria
January 3, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Chemically-Induced Disorders
- Substance-Related Disorders
- Tobacco Use Disorder
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Cholinergic Agents
- Ganglionic Stimulants
- Nicotinic Agonists
- Cholinergic Agonists
- Nicotine
Other Study ID Numbers
- 1401452
- R21CA234003 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Data will not be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on Control mHealth program
-
Chinese University of Hong KongNot yet recruitingMetabolic Syndrome
-
Chang Gung Memorial HospitalCompleted
-
Mackay Medical CollegeCompletedOverweight and Obese Pregnant WomenTaiwan
-
The Hong Kong Polytechnic UniversityCompleted
-
Liverpool John Moores UniversityLiverpool Heart and Chest Hospital NHS Foundation Trust; University Hospitals... and other collaboratorsCompleted
-
Universidad Autonoma de MadridUniversidad Rey Juan CarlosNot yet recruitingFibromyalgia (FM)
-
University of TorontoRecruitingSocial Skills | Financial Stress | Social FunctioningUganda
-
ISA Associates, Inc.CompletedColorectal CancerUnited States
-
Boston University Charles River CampusWashington University School of MedicineCompletedParkinson DiseaseUnited States
-
China Medical University HospitalMinistry of Science and Technology, Taiwan; China Medical University, TaiwanCompletedHealth Behavior | Intervention StudyTaiwan